Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 06-2002 | 06-2001 | 06-2000 | 06-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -161 | 1,871 | 396 | 533 | 4,281 |
| Depreciation Amortization | 281 | 321 | 954 | 940 | 448 |
| Income taxes - deferred | -194 | 1,053 | 616 | 426 | 322 |
| Accounts receivable | 1,814 | 1,098 | -2,519 | 120 | 4,083 |
| Accounts payable and accrued liabilities | -15 | -489 | 564 | -129 | -1,248 |
| Other Working Capital | 593 | 582 | -1,381 | -1,063 | 1,766 |
| Other Operating Activity | -1,799 | -609 | 1,955 | 9 | -2,835 |
| Operating Cash Flow | $519 | $3,827 | $585 | $836 | $6,817 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71 | -82 | -83 | -144 | -77 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -4,598 |
| Investing Cash Flow | $-71 | $-82 | $-83 | $-144 | $-4,675 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -3,600 | -1,700 | -1,700 | N/A |
| Common Stock Issued | N/A | N/A | N/A | 35 | 41 |
| Financing Cash Flow | $N/A | $-3,600 | $-1,700 | $-1,665 | $41 |
| Beginning Cash Position | 1,474 | 1,329 | 2,527 | 3,500 | 1,317 |
| End Cash Position | 1,922 | 1,474 | 1,329 | 2,527 | 3,500 |
| Net Cash Flow | $448 | $145 | $-1,198 | $-973 | $2,183 |
| Free Cash Flow | |||||
| Operating Cash Flow | 519 | 3,827 | 585 | 836 | 6,817 |
| Capital Expenditure | -71 | -82 | -83 | -144 | -77 |
| Free Cash Flow | 448 | 3,745 | 502 | 692 | 6,740 |